KAREN MCCLEAF: Open Payments
NPI 1316148513 · HOLLYWOOD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 24 payments from 13 companies in 2025. Trend: 2023 $1,247 · 2024 $845 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $168 |
| Amgen Inc. | 4 | $72 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| PFIZER INC. | 3 | $55 |
| Actelion Pharmaceuticals US, Inc. | 1 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: The Cologuard Plus Collection Kit, Cologuard Collection Kit, ELIQUIS, REPATHA, VERQUVO, UPTRAVI, FARXIGA, JARDIANCE.
Industry payments across MD — which companies pay providers there.
